Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Oxytocin on Resting State Neurophysiological Measures
NCT03255148Phase 1Completed
- Sponsor
- KU Leuven
- Start
- Jul 2017
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray (2 arms), sponsored by KU Leuven. Primary endpoint: Change in heart rate variability at 5 minutes. Started Jul 2017; status: completed.
02
Drugs
oxytocin nasal spray
Beyond the preview
Go deeper on NCT03255148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255148.